Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1/2 brentuximab vedotin in comb w/ nivolumab w/ relap/refractory Hodgkin lymphoma

Protocol: OSU-15164

Full Title

A phase I/II study evaluating brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma after failure of frontline therapy

Lymphoma Hodgkin’s Lymphoma